Avenue Therapeutics Inc (ATXI)
3.815
+0.18
(+5.10%)
USD |
NASDAQ |
May 17, 16:00
3.88
+0.06
(+1.70%)
After-Hours: 20:00
Avenue Therapeutics 1 Year Total Returns (Daily): -95.40% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -95.40% |
May 16, 2024 | -95.48% |
May 15, 2024 | -95.45% |
May 14, 2024 | -95.19% |
May 13, 2024 | -95.05% |
May 10, 2024 | -94.87% |
May 09, 2024 | -94.55% |
May 08, 2024 | -94.25% |
May 07, 2024 | -94.51% |
May 06, 2024 | -94.10% |
May 03, 2024 | -93.69% |
May 02, 2024 | -93.47% |
May 01, 2024 | -93.55% |
April 30, 2024 | -92.97% |
April 29, 2024 | -93.66% |
April 26, 2024 | -90.92% |
April 25, 2024 | -87.13% |
April 24, 2024 | -90.32% |
April 23, 2024 | -86.99% |
April 22, 2024 | -87.37% |
April 19, 2024 | -87.96% |
April 18, 2024 | -87.54% |
April 17, 2024 | -88.25% |
April 16, 2024 | -87.94% |
April 15, 2024 | -88.53% |
Date | Value |
---|---|
April 12, 2024 | -88.11% |
April 11, 2024 | -87.83% |
April 10, 2024 | -87.83% |
April 09, 2024 | -88.15% |
April 08, 2024 | -87.62% |
April 05, 2024 | -88.46% |
April 04, 2024 | -88.24% |
April 03, 2024 | -87.37% |
April 02, 2024 | -87.12% |
April 01, 2024 | -87.12% |
March 28, 2024 | -86.08% |
March 27, 2024 | -85.87% |
March 26, 2024 | -85.75% |
March 25, 2024 | -85.38% |
March 22, 2024 | -85.74% |
March 21, 2024 | -84.92% |
March 20, 2024 | -85.06% |
March 19, 2024 | -85.59% |
March 18, 2024 | -85.59% |
March 15, 2024 | -86.54% |
March 14, 2024 | -86.86% |
March 13, 2024 | -85.05% |
March 12, 2024 | -84.24% |
March 11, 2024 | -85.41% |
March 08, 2024 | -81.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.61%
Minimum
Feb 23 2022
158.1%
Maximum
Oct 10 2019
-34.92%
Average
-74.25%
Median
Jun 05 2023
1 Year Total Returns (Daily) Benchmarks
Fortress Biotech Inc | -81.03% |
SINTX Technologies Inc | -94.37% |
Deciphera Pharmaceuticals Inc | 84.49% |
Flora Growth Corp | -71.52% |
NovaBay Pharmaceuticals Inc | -83.53% |